Ibogaine clinic appoints Tania Gonzalez as lead therapist

New leadership at Ibogaine by David Dardashti

Ibogaine by David Dardashti, a leading international research and treatment facility, has appointed Tania Gonzalez as its new Lead Therapist. Announced on October 10, 2026, Gonzalez will focus on enhancing pre-treatment psychological protocols and spearheading clinical research into ibogaine therapy's psychological effects.

Focus on Jungian psychological assessments

Gonzalez's role will involve conducting comprehensive pre-ibogaine assessments using Jungian archetypes such as the Hero, the Shadow, and the Trickster. These evaluations aim to map patients' subconscious minds, providing a structured framework for their introspective journeys during ibogaine therapy. By establishing an archetype baseline, the clinic seeks to deepen clients' exploration of the collective unconscious.

Research initiatives and demographic studies

In addition to her assessment duties, Gonzalez will lead a prospective peer-reviewed study. This research will examine how demographic factors like age and mental health profiles influence psychological outcomes during ibogaine treatment. It will also explore how dosing variations affect treatment experiences and identify subconscious trends in pre-treatment assessments.

Why it matters

The appointment of Gonzalez underscores the clinic's commitment to integrating ancient psychoanalytic frameworks with modern psychedelic medicine. Her work aims to optimize dosing protocols and contribute valuable empirical data to the scientific community, enhancing the understanding of ibogaine's therapeutic potential.

Ibogaine by David Dardashti, founded by Rabbi David Dardashti, has been a key player in ibogaine therapy for over two decades, focusing on treating addiction, trauma, and anxiety in a holistic environment.